[The treatment of patients with duodenal peptic ulcer with a synthetic prostaglandin E2 analog (enprostil)].
Loginov
A S
AS
Zverkov
I V
IV
Kondashova
Z D
ZD
Sokolova
G N
GN
Minushkin
O N
ON
D000293:Adolescent; D000328:Adult; D001706:Biopsy; D004341:Drug Evaluation; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000503:physiopathology; D004386:Duodenum / Q000473:pathology; D016620:Enprostil / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism; D005755:Gastrins / Q000097:blood / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010295:Parietal Cells, Gastric / Q000187:drug effects; D013270:Stomach / Q000473:pathology
D005755:Gastrins; D016620:Enprostil
Lechenie bol'nykh iazvennoĭ bolezn'iu dvenadtsatiperstnoĭ kishki sinteticheskim analogom prostaglandina E2 (énprostilom).